EUVIMEDEUVIMED entdecken
Crossref

Potent Anticancer Tethered Organorhodium(III) Complexes Target the Mitochondria

Arturo Villechenous Rojo iD, Vanessa Rodríguez-Fanjul iD, Ana M Pizarro iD

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.6c02209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Arturo Villechenous Rojo und 2 weiteren Autor:innen. Beteiligte Einrichtung: IMDEA Nanociencia , Faraday 9, 28049Madrid, Spain. Hauptthemen laut MEDLINE: Mitochondria, Rhodium, Antineoplastic Agents, Coordination Complexes. Die Arbeit nennt 74 Literaturangaben. Gefördert von: Comunidad de Madrid, Agencia Estatal de Investigaci?n.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a family of tethered rhodium(III) complexes of formula [Rh(η5:κ1-C5Me4(CH2)npyN)(C,N)]+ (n = 1 or 2; C,N = 2-phenylpyridine or benzoquinoline), their nontethered analogues, and their iridium(III) counterparts. The tethered pyridine, κ1-coordinated to the metal, does not dissociate in water, yet the metal–Npy(tether) bond can be cleaved by strong nucleophiles, enabling metal activation. We corroborated that metal–Z bond reactivity correlated with cytotoxicity in breast cancer cells; complexes lacking reactive metal–Z bonds exhibited low anticancer potency, while excessive reactivity impaired efficacy likely through off-target reactions. For the highly potent tethered complexes, we determined the kinetics of pyridine cleavage using DMSO and confirmed that N-acetylcysteine can also promote pyridine dissociation. In tethered complexes, metal-mediated reactivity is crucial to potency, as metal-pyridine bonds with higher activation energy produce complexes less damaging to cells. We confirmed mitochondrial involvement in cell death, demonstrating that the most cytotoxic complexes inhibit OXPHOS more efficiently.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaRhodiumAntineoplastic AgentsCoordination ComplexesHumansCell Line, TumorStructure-Activity RelationshipPyridinesIridiumDrug Screening Assays, AntitumorOrganometallic Compounds

Substanzen

RhodiumAntineoplastic AgentsCoordination ComplexesPyridinesIridiumOrganometallic Compounds

Autor:innen und Institutionen

  • IMDEA Nanociencia , Faraday 9, 28049Madrid, Spain.

ORCID-Profile: Arturo Villechenous Rojo, Vanessa Rodríguez-Fanjul, Ana M Pizarro

Förderung

  • Comunidad de Madrid
  • Agencia Estatal de Investigaci?n

Zitieren

APA

Villechenous Rojo, A., Rodríguez-Fanjul, V., & Pizarro, A. M. (2026). Potent Anticancer Tethered Organorhodium(III) Complexes Target the Mitochondria. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02209

Vancouver

Villechenous Rojo A, Rodríguez-Fanjul V, Pizarro AM. Potent Anticancer Tethered Organorhodium(III) Complexes Target the Mitochondria. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c02209

BibTeX
@article{VillechenousRojo2026,
  author = {Villechenous Rojo, Arturo and Rodríguez-Fanjul, Vanessa and Pizarro, Ana M},
  title = {Potent Anticancer Tethered Organorhodium(III) Complexes Target the Mitochondria},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c02209}
}
Kostenlos starten →